USPTO serial 79317129
PROSTROLANE BLANC-B
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- JOHNSON, BRITTANY S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PROSTROLANE BLANC-B?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of arthritis; medicines for human purposes, namely, medicinal preparations for the treatment of knee joint inflammation; pharmaceutical preparations for the treatment of dermatological conditions and skin conditions; pharmaceutical preparations for the care of the skin; pharmaceutical preparations for dermatological use; pharmaceutical preparations for the treatment of knee joint inflammation; non-prescription medicines, namely, medicinal preparations for the treatment of the skin and for dermatological use; non-prescription medicines, namely, medicinal preparations for the treatment of knee joint inflammation; skin care preparations for medical purposes; pharmaceutical products for the treatment of bone diseases; acne medication; implants comprising living tissue; hair growth stimulants; pharmacological preparations for skin care in the nature of pharmaceutical preparations for skin care; filled syringes sold filled with dermatological preparations for medical purposes; pharmaceuticals, namely, pre-filled syringes used for filling wrinkles, folds, scars, lips for face and body contouring and for skin rejuvenation, and used for treatment of inflammation of joints; pharmaceuticals, namely, pre-filled syringes used for skin fillers; injectable dermal fillers for use in the treatment of cellulite, folds, scars, and body contouring and for rejuvenating the skin; implantable medicines, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for skin conditions; implantable medicines, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of knee joint inflammation; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; synthetic peptides for the treatment of skin conditions for pharmaceutical purposes; synthetic peptides for the treatment of knee joint inflammation for pharmaceutical purposes; injectable dermal fillers; filled syringes for medical purposes containing injectable dermal fillers; medical preparations for slimming purposes; pain relief preparations; surgical implants grown from stem cells comprising living tissues; nutraceuticals for use as dietary supplements | ACTIVE | — |
| 010 | Implants consisting of artificial materials; implants consisting of artificial materials in gel form; medical prostheses, namely, prostheses for joint; medical apparatus, namely, syringes, infusion and injection devices for injecting fillers; implantable subcutaneous drug delivery devices in the nature of implantable drug delivery ports; medical apparatus and instruments for arthritis treatment; joint pain therapy apparatus, namely, therapeutic apparatus in the nature of body limb thermal compression undergarments for relief of joint pain through targeted thermal application and compression; syringes for injections; bone void fillers comprised of artificial materials; injection device for pharmaceuticals; medical apparatus for facilitating the inhalation of pharmaceutical preparations; medical apparatus and instruments for use in general surgery, other than for dental purposes; drug delivery devices sold empty, namely, syringes; medical implants, namely, a polymer gel for filling wounds and lips, contouring the face and body, and rejuvenating the skin; medical implants, namely, a polymer gel used for wrinkle and scar treatment, lip, face, body contour and skin regeneration; disposable syringes; medical skin care apparatus in the nature of a medical apparatus for measuring skin hydration; fluid injectors for medical purposes; silicone preparations for cosmetic implantation, namely, silicone gel sheeting for the treatment of scars; massaging apparatus for personal use | ACTIVE | — |
| 035 | Promoting the goods and services of others by means of operating an on-line comprehensive shopping mall; business intermediary services relating to mail order by telecommunications, namely, order fulfillment services; retail store services featuring medical apparatus and instruments other than for dental purposes; wholesale store services featuring medical apparatus and instruments other than for dental purposes; retail store services featuring medicines for human purposes; wholesale store services featuring medicines for human purposes; wholesale store services featuring cosmetics; retail store services featuring cosmetics; wholesale store services featuring nutraceuticals for use as dietary supplements; retail store services featuring nutraceuticals for use as dietary supplements; wholesale store services featuring medical apparatus for injecting fillers; retail store services featuring medical apparatus for injecting fillers; wholesale store services featuring massaging apparatus for personal use; retail store services featuring massaging apparatus for personal use; wholesale store services featuring synthetic peptides for pharmaceutical purposes; retail store services featuring synthetic peptides for pharmaceutical purposes; wholesale store services featuring medical apparatus and instruments for arthritis treatment; retail store services featuring medical apparatus and instruments for arthritis treatment; wholesale store services featuring injectable dermal fillers; retail store services featuring injectable dermal fillers; wholesale store services featuring pharmaceutical preparations for the treatment of arthritis; retail store services featuring pharmaceutical preparations for the treatment of arthritis; wholesale store services featuring medical preparations for slimming purposes; retail store services featuring medical preparations for slimming purposes; wholesale store services featuring implants consisting of artificial materials; retail store services featuring implants consisting of artificial materials; marketing services; advertising services; commercial intermediation services in the nature of mediation of trade business for third parties; import-export agency services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named PROSTROLANE BLANC-B
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 14, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 14, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 21, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 19, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 20, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 27, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 26, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 4, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 29, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 13, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 26, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 26, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 26, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 25, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 6, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 5, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |